Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,423,604
-
Share change
-
-22,779
-
Total reported value
-
$263,758,000
-
Price per share
-
$19.68
-
Number of holders
-
32
-
Value change
-
+$656,520
-
Number of buys
-
23
-
Number of sells
-
13
Institutional Holders of SATSUMA PHARMACEUTICALS INC - COM (STSA) as of Q4 2019
As of 31 Dec 2019,
SATSUMA PHARMACEUTICALS INC - COM (STSA) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,423,604 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, TPG Group Holdings (SBS) Advisors, Inc., CITADEL ADVISORS LLC, Cormorant Asset Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., CAXTON CORP, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, and BlackRock Inc..
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.